Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
2.620
+0.060 (2.34%)
At close: Jun 27, 2025, 4:00 PM
2.520
-0.100 (-3.82%)
After-hours: Jun 27, 2025, 7:01 PM EDT
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $49.00 million as of June 27, 2025.
Market Cap
49.00M
Enterprise Value
-51.96M
1-Year Change
n/a
Ranking
Category
Stock Price
$2.62
Market Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $49.00M, a decrease of -77.16%. That is a compound annual growth rate of -99.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 49.00M | -77.16% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |